Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 16, 2018
Reporting Period: This filing reports on events occurring on March 16, 2018, specifically regarding upcoming investor presentations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The report focuses solely on the disclosure of an investor presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: Executive officers have scheduled upcoming presentations for investors and analysts.
- Exhibit 99.1: The company intends to use the "OrthoPediatrics Corp. Investor Presentation dated March 2018" (filed as Exhibit 99.1) in whole or in part during these meetings.
- Legal Status: The information provided in this Item 7.01 and the referenced exhibit is furnished, not "filed," for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Emerging Growth Company: The registrant is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation dated March 2018) for actual financial data, guidance, and strategic outlook, as this 8-K only references the document.
- Confirm the specific dates and times of the upcoming investor presentations mentioned by management.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained within the referenced presentation.